Log In
BCIQ
Print this Print this
 

Spiriva Respimat, tiotropium bromide

Also known as: Spiriva Respimat Soft Mist

  Manage Alerts
Collapse Summary General Information
Company Boehringer Ingelheim GmbH
DescriptionOnce-daily inhaled Spiriva tiotropium, a long-acting muscarinic antagonist (LAMA), delivered via the Respimat Inhaler
Molecular Target Muscarinic acetylcholine receptor M3 (CHRM3) (HM3)
Mechanism of ActionMuscarinic acetylcholine receptor M3 antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/30/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today